.

Swiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 Treatment

Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the...

from NDTV News - World-news https://ift.tt/2YkZlPf

Resent New

Discord abandons Microsoft acquisition talks: Report

Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...

Most popular News